Biohaven (BHVN) Operating Expenses (2021 - 2026)

Biohaven (BHVN) has 6 years of Operating Expenses data on file, last reported at $130.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 41.13% year-over-year to $130.4 million; the trailing twelve-month figure through Mar 2026 stood at $654.2 million (down 29.15% YoY), and the FY2025 full-year result was $745.4 million, down 15.79% from the prior year.
• Operating Expenses eased to $130.4 million in Q1 2026, from $142.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $333.8 million in Q2 2024 to a low of $67.6 million in Q3 2022.
• A 5-year average of $162.6 million and a median of $169.4 million in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 319.42% in 2022 and slumped 52.31% in 2023, its largest moves.
• Tracing BHVN's Operating Expenses over 5 years: stood at $213.4 million in 2022, then fell by 27.97% to $153.7 million in 2023, then climbed by 23.56% to $189.9 million in 2024, then retreated by 24.85% to $142.7 million in 2025, then dropped by 8.62% to $130.4 million in 2026.
• Business Quant data shows BHVN's Operating Expenses at $130.4 million in Q1 2026, $142.7 million in Q4 2025, and $169.4 million in Q3 2025.